Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Mojca Lunder

4PUBLICATIONS

6CO-AUTHORS

Food properties (incl. characteristics and health benefits)Cancer therapy (excl. chemotherapy and radiation therapy)Epidemiological modellingMolecular medicine

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (4)

Sort by Publication Date:

|Jul 04, 2025

Rosuvastatin Improved LDL Subfractions Profile in a Patient with Type 1 Diabetes Following a Ketogenic Diet: A Case Report.

Miodrag Janić, Mojca Lunder, Andrej Janež

|May 27, 2022

Empagliflozin-Metformin Combination Has Antioxidative and Anti-Inflammatory Properties that Correlate with Vascular Protection in Adults with Type 1 Diabetes.

Miodrag Janić, Matej Cankar, Jan Šmid

|Dec 05, 2018

Empagliflozin on top of metformin treatment improves arterial function in patients with type 1 diabetes mellitus.

Mojca Lunder, Miodrag Janić, Miha Japelj

|Mar 31, 2015

A low-dose combination of fluvastatin and valsartan: a new "drug" and a new approach for decreasing the arterial age.

Miodrag Janić, Mojca Lunder, Mišo Šabovič

Pageof 1

Frequent Collaborators

2 joint publications

Miodrag Janić

2 joint publications

Mišo Šabovič

2 joint publications

Andrej Janež

1 joint publications

Alenka France Štiglic

1 joint publications

Aleš Jerin

1 joint publications

Manfredi Rizzo

Frequent Collaborators

2 joint publications

Miodrag Janić

2 joint publications

Mišo Šabovič

2 joint publications

Andrej Janež

1 joint publications

Alenka France Štiglic

Top Related Videos

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on : Nov 10, 2017

Antagonistic Effect of Jiawei Shengjiang San on a Rat Model of Diabetic Nephropathy: Related to EGFR/MAPK3/1 Signaling Pathway

Antagonistic Effect of Jiawei Shengjiang San on a Rat Model of Diabetic Nephropathy: Related to EGFR/MAPK3/1 Signaling Pathway

Published on : May 10, 2024

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

Published on : Feb 28, 2013

See more related videos

Top Related Videos

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on : Nov 10, 2017

Antagonistic Effect of Jiawei Shengjiang San on a Rat Model of Diabetic Nephropathy: Related to EGFR/MAPK3/1 Signaling Pathway

Antagonistic Effect of Jiawei Shengjiang San on a Rat Model of Diabetic Nephropathy: Related to EGFR/MAPK3/1 Signaling Pathway

Published on : May 10, 2024

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

Published on : Feb 28, 2013

See more related videos